Browse the evidence

Neither glycogen depletion nor phosphorylation of relevant signalling proteins showed any difference between conditions of load and repetition duration.

Resistance training outcomes are not influenced by glycogen depletion or signalling protein changes based on load or repetition duration.

Current pharmacologic options for obesity management are largely limited in number and of modest efficacy/safety profile.

Practitioners should be aware of the limitations of existing obesity medications.

There is an urgent need for safe and more efficacious new agents for obesity treatment.

There is a pressing need for practitioners to seek out and consider new treatment options.

Emerging pharmacologic agents and alternative approaches targeting obesity pathways are being explored.

Practitioners should stay informed about new pharmacologic agents and alternative approaches in obesity treatment.

Glucose ingestion during exercise decreases the expression of genes involved in lipid metabolism.

Practitioners should consider that glucose ingestion during exercise may hinder fat metabolism.

SCD1 is a key enzyme that regulates energy homeostasis and various physiological processes.

Understanding SCD1's role can help in targeting metabolic diseases.

Aberrant activation of SCD1 contributes to obesity, non-alcoholic fatty liver, diabetes, and cancer.

Targeting SCD1 may help in managing these metabolic diseases.

Insulin resistance is associated with a breakdown in lipid dynamics.

Recognizing the role of lipid dynamics in insulin resistance can inform treatment strategies.

The exercise-diet manipulation significantly affected the transcription of all carbohydrate-related genes, increasing GLUT4 and glycogenin mRNA abundance after a high-carbohydrate diet.

Dietary strategies that increase carbohydrate intake can enhance the expression of genes involved in glucose metabolism.

Low muscle glycogen content has variable effects on the basal transcription of select metabolic and myogenic genes at rest.

Practitioners should consider that low glycogen levels may not uniformly affect gene expression related to muscle growth.

Differences in basal transcription of metabolic and myogenic genes are abolished after a single bout of heavy resistance training.

Resistance training may negate the effects of low glycogen on gene expression.

Commencing resistance exercise with low muscle glycogen does not enhance the activity of genes implicated in promoting hypertrophy.

Practitioners should note that low glycogen levels prior to resistance training do not promote muscle growth-related gene activity.

OSM levels correlate with body weight and insulin and are inversely correlated with glucose disposal rate.

Monitoring OSM levels could provide insights into metabolic health in obese individuals.

Increased contractile activity activates key kinases and phosphatases involved in signal transduction.

Understanding these signaling pathways can help in designing effective training programs.

Higher fetuin-A is associated with a 19% higher risk of incident diabetes mellitus in older persons for each 0.10-g/L increase in fetuin-A concentration.

Monitoring fetuin-A levels may help identify older adults at higher risk for developing diabetes.

The loss of the uricase gene may predispose humans to obesity.

Awareness of genetic factors like the uricase gene can enhance obesity risk assessments.

AM833 has a unique pharmacological profile across diverse measures of receptor binding, activation, and regulation.

Understanding AM833's unique profile can inform its therapeutic use.

Arachidonic acid (AA) levels were not associated with higher risk of cardiovascular outcomes, and higher levels were associated with lower risk of total CVD with a hazard ratio of 0.92 (95% CI, 0.86-0.99).

Arachidonic acid may not increase cardiovascular risk and could be beneficial at higher levels.

Insulin sensitizers such as PPARγ (pioglitazone) and pan-PPARs agonists (lanifibranor) have shown beneficial effects on both NASH and liver fibrosis.

Consider insulin sensitizers as part of the treatment plan for NASH and liver fibrosis.

The hazard ratio of type 2 diabetes per increment of 10 risk alleles in the polygenic risk score is 1.64 (95% CI 1.54 to 1.75).

Genetic predisposition significantly increases the risk of developing type 2 diabetes.

The LCT genotype with 1 or 2 T allele was significantly associated with higher dairy intake and higher BMI.

Genetic factors may influence how dairy intake affects BMI.

Dapagliflozin lowers blood glucose independent of insulin secretion and action.

Dapagliflozin can be used to manage blood glucose levels without relying on insulin.

Micronutrients like polyphenols, carotenoids, and vitamins affect oxidative stress, endothelial function, and lipid and glucose homeostasis.

Encouraging the intake of micronutrient-rich foods may support cardiovascular health.

The physiological role of signaling targets in exercise-mediated responses on metabolism and gene expression is discussed.

Insights into these roles can inform nutritional strategies to optimize exercise outcomes.